Anticorps Polyclonal de lapin anti-LATS2-Specific

• Phare
• Validé par KD/KO

LATS2-Specific Polyclonal Antibody for WB, IP, IF, IHC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris

Applications

WB, IHC, IF/ICC, IP, CoIP, ELISA

Conjugaison

Non conjugué

Publications

31

N° de cat : 20276-1-AP

Synonymes

KPM, LATS2, LATS2-Specific, Warts like kinase

---

Galerie de données de validation

• 

  WB analysis of SGC-7901 using 20276-1-AP

  SGC-7901 cells were subjected to SDS PAGE followed by western blot with 20276-1-AP (LATS2-Specific antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of human heart using 20276-1-AP

  human heart tissue were subjected to SDS PAGE followed by western blot with 20276-1-AP (LATS2-Specific antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of mouse brain using 20276-1-AP

  mouse brain tissue were subjected to SDS PAGE followed by western blot with 20276-1-AP (LATS2-Specific antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  IP experiment of HEK-293 using 20276-1-AP

  IP result of anti-LATS2-Specific (IP:20276-1-AP, 4ug; Detection:20276-1-AP 1:300) with HEK-293 cells lysate 2320 ug.

• 

  IHC staining of human liver cancer using 20276-1-AP

  Immunohistochemical analysis of paraffin-embedded human liver cancer tissue slide using 20276-1-AP (LATS2-Specific antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human liver cancer using 20276-1-AP

  Immunohistochemical analysis of paraffin-embedded human liver cancer tissue slide using 20276-1-AP (LATS2-Specific antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human liver cancer using 20276-1-AP

  Immunohistochemical analysis of paraffin-embedded human liver cancer tissue slide using 20276-1-AP (LATS2-Specific antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of mouse skeletal muscle using 20276-1-AP

  Immunohistochemical analysis of paraffin-embedded mouse skeletal muscle tissue slide using 20276-1-AP (LATS2-Specific antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of mouse skeletal muscle using 20276-1-AP

  Immunohistochemical analysis of paraffin-embedded mouse skeletal muscle tissue slide using 20276-1-AP (LATS2-Specific antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human colon using 20276-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon using 20276-1-AP (LATS2-Specific antibody) at dilution of 1:100 (under 10x lens).

• 

  IHC staining of human colon using 20276-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon using 20276-1-AP (LATS2-Specific antibody) at dilution of 1:100 (under 40x lens).

• 

  IF Staining of HepG2 using 20276-1-AP

  Immunofluorescent analysis of HepG2 cells using 20276-1-AP (LATS2-Specific antibody) at dilution of 1:50 and Alexa Fluor 488-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L).

---

Applications testées

• Résultats positifs en WB: cellules SGC-7901, tissu cardiaque humain, tissu cérébral de souris
• Résultats positifs en IP: cellules HEK-293,
• Résultats positifs en IHC: tissu de cancer du foie humain, tissu de côlon humain, tissu de muscle squelettique de souris; il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
• Résultats positifs en IF/ICC: cellules HepG2

Dilution recommandée

• Western Blot (WB): WB : 1:500-1:2000
• Immunoprécipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
• Immunohistochimie (IHC): IHC : 1:50-1:500
• Immunofluorescence (IF)/ICC: IF/ICC : 1:20-1:200

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• KD/KO: See 5 publications below
• WB: See 27 publications below
• IHC: See 8 publications below
• IF: See 3 publications below
• IP: See 1 publications below
• CoIP: See 2 publications below

Informations sur le produit

20276-1-AP cible LATS2-Specific dans les applications de WB, IHC, IF/ICC, IP, CoIP, ELISA et montre une réactivité avec des échantillons Humain, souris

• Réactivité: Humain, souris
• Réactivité citée: Humain, souris
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: Peptide
• Nom complet: LATS, large tumor suppressor, homolog 2 (Drosophila)
• Masse moléculaire calculée: 120 kDa
• Poids moléculaire observé: 130-150 kDa
• Numéro d’acquisition GenBank: NM_014572
• Symbole du gène: LATS2
• Identification du gène (NCBI): 26524
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

LATS2, also named as KPM, belongs to the protein kinase superfamily and AGC Ser/Thr protein kinase family. LATS2 is a tumor suppressor which plays a critical role in centrosome duplication, maintenance of mitotic fidelity and genomic stability. It negatively regulates G1/S transition by down-regulating cyclin E/CDK2 kinase activity. It is a negative regulator of the androgen receptor. LATS2 has a calculated molecular mass of 120 kDa and an apparent molecular mass of 150 kDa (PMID: 10871863). The antibody is specific to LATS2.

Publications

Species	Application	Title
human	WB	Mol Cancer; Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer; Authors - Yufan Ying
mouse	WB	Cell Metab; Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis.; Authors - Xiaobo Wang ; KD Validated
human	WB	Cell Death Differ; The Hippo signaling component LATS2 enhances innate immunity to inhibit HIV-1 infection through PQBP1-cGAS pathway.; Authors - Tian-Sheng He ; KO Validated
human	WB, CoIP	Clin Transl Med; Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway.; Authors - Jing Chen
human	WB,IHC	Oxid Med Cell Longev; miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.; Authors - Tangwei Wu
human	WB	Oncogene; TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.; Authors - Sha Zhou